E A Koller

Summary

Affiliation: Food and Drug Administration
Country: USA

Publications

  1. ncbi request reprint Retinal changes mimicking diabetic retinopathy in two nondiabetic, growth hormone-treated patients
    E A Koller
    U S Food and Drug Administration CDER, Rockville, Maryland 20857, USA
    J Clin Endocrinol Metab 83:2380-3. 1998
  2. ncbi request reprint Aseptic necrosis in HIV seropositive patients: a possible etiologic role for megestrol acetate
    E Koller
    Center for Drug Evaluation and Research, Food and Drug Administration, Rockville, Maryland, USA
    AIDS Patient Care STDS 14:405-10. 2000

Collaborators

Detail Information

Publications2

  1. ncbi request reprint Retinal changes mimicking diabetic retinopathy in two nondiabetic, growth hormone-treated patients
    E A Koller
    U S Food and Drug Administration CDER, Rockville, Maryland 20857, USA
    J Clin Endocrinol Metab 83:2380-3. 1998
    ..043 mg/ kg.day for the following 5 months. Cumulative laboratory and clinical observations suggest that GH and related peptides have a role in retinal pathology independent of the degree of glucose tolerance...
  2. ncbi request reprint Aseptic necrosis in HIV seropositive patients: a possible etiologic role for megestrol acetate
    E Koller
    Center for Drug Evaluation and Research, Food and Drug Administration, Rockville, Maryland, USA
    AIDS Patient Care STDS 14:405-10. 2000
    ..Cachectic acquired immunodeficiency syndrome (AIDS) patients may have additional risk factors that predispose them to aseptic necrosis when receiving megestrol acetate...